4th Quarter - Report

MAYO CLINIC for MAYO CLINIC

Firm
Client
Income
—
Expenses
$200,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

Telemedicine technology; New diagnostic tests, Precision medicine; Broadband expansion and Internet access; Privacy and data security and usage

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); SENATE; White House Office; Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Veterans VET

Reimbursement and coverage issues related to VA health care and Tricare

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA); White House Office; Veterans Affairs, Dept of (VA); Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); SENATE

Immigration IMM

Changes to the immigration status of foreign doctors, students, and patients

LobbyistCovered position, as disclosed
SARAH CURTIS Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: Executive Office of the President (EOP); Office of the Vice President of the United States; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Drug shortages

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: Food & Drug Administration (FDA); SENATE; Veterans Affairs, Dept of (VA); White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Office of the Vice President of the United States

Health Issues HCR

Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; White House Office; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA)

Bills named: S. 178 (116th), H.R. 748 (116th), H.R. 266 (116th), H.R. 6074 (116th), H.R. 6800 (116th), H.R. 6201 (116th)

Medicare/Medicaid MMM

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); White House Office; Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES

Bills named: S. 178 (116th), H.R. 6800 (116th), H.R. 6074 (116th), H.R. 6201 (116th), H.R. 748 (116th), H.R. 266 (116th)

Medical/Disease Research/Clinical Labs MED

Reimbursements and lab payments including PAMA and S. 6102, the Verifying Accurate Leading-edge IVCT Development Act of 2020; Regulation of and reimbursements for testing related to COVID-19; Medical research funding; Regulatory relief; Laboratory diagnostic tests; Rural health; Innovation in treatments for COVID-19 including convalescent plasma

LobbyistCovered position, as disclosed
SARAH CURTIS New Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; SENATE; White House Office; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 6102 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.